(Q41507911)

1 October 2017

1 reference

title

Endometrial cancer and hormone replacement therapy. Appropriate use of progestins to oppose endogenous and exogenous estrogen (English)

1 reference

1 October 2017

1 reference

Sulak PJ

1

1 reference

1 October 2017

publication date

1 June 1997

1 reference

Endocrinology and Metabolism Clinics of North America

1 October 2017

published in

1 reference

1 October 2017

volume

26

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

399-412

1 reference

On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Outpatient endometrial sampling with the Pipelle curette.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Two pathogenetic types of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Tamoxifen for breast cancer: associated endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding — a Nordic multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

A randomized comparison of the Pipelle, Accurette, and Explora endometrial sampling devices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Vaginosonography for early detection of endometrial carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Progestin challenge test in postmenopausal patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

Accuracy of pipelle endometrial sampling in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970255-3

7 January 2021

10.1016/S0889-8529(05)70255-3

Identifiers

DOI

1 reference

1 October 2017

1 reference